Log in to search using one of your social media accounts:

 

Varian supports lung cancer trial
Radiation therapy firm Varian Medical Systems is endorsing a phase III trial...Read more on AuntMinnie.comRelated Reading: Varian opens office in Algeria Varian launches new Beacon transponder Varian preps new products for ECR 2016 Varian posts mixed Q1 results Varian gets Saudi OK for proton therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 21, 2016 Category: Radiology Source Type: news

DITTA endorses refurbishment standards
The Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association...Read more on AuntMinnie.comRelated Reading: JIRA begins 2-year chairmanship of DITTA (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2016 Category: Radiology Source Type: news

Delay in Radiation Increases Ipsilateral Breast Cancer RiskDelay in Radiation Increases Ipsilateral Breast Cancer Risk
Women eligible for adjuvant radiation therapy increase their risk for ipsilateral breast cancer if they delay getting radiation therapy 8 weeks beyond surgery. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 20, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Delaying radiation therapy for women with very early breast cancer ups recurrence
Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as 'stage 0,' breast cancer, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 19, 2016 Category: Science Source Type: news

Study: SBRT has 98 percent cure rate for prostate cancer
Stephen FellerDALLAS, April 18 (UPI) -- An alternative method of delivering radiation therapy to prostate cancer patients had a nearly 100 percent cure rate, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 18, 2016 Category: Consumer Health News Source Type: news

98 percent cure rate for prostate cancer using stereotactic body radiation therapy, research shows
A new study -- the first trial to publish five-year results from SBRT treatment for prostate cancer -- found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 18, 2016 Category: Science Source Type: news

Delayed rad therapy puts women with DCIS at risk
Women being treated for ductal carcinoma in situ (DCIS) are at higher risk...Read more on AuntMinnie.comRelated Reading: Socioeconomic factors affect patient care in radiology Racial discrepancies persist in breast cancer diagnoses Choosing Wisely boosts use of short-course breast radiation therapy Accelerated RT with boost works well for breast cancer patients ASTRO publishes guidelines for accelerated whole-breast RT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 18, 2016 Category: Radiology Source Type: news

Varian backs Phase III non-small cell lung cancer trial
Varian Medical (NYSE:VAR) said today it is supporting a Phase III clinical trial set to compare outcomes of radiosurgery against surgical resection for treating early-stage, high-risk operable non-small cell lung cancer. The randomized “Stablemates Trial” will test the hypothesis that 3-year overall survival in high risk operable patients with Stage I NSCLC is equivalent or greater in patients who undergo stereotactic ablative radiotherapy compared to conventional surgery, the company said. “In addition to a potentially longer survival rate, SAbR may benefit some lung cancer patients by off...
Source: Mass Device - April 18, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Oncology Radiosurgery Varian Medical Systems Source Type: news

Delaying radiation therapy for women with very early breast cancer ups recurrence
(Washington University School of Medicine) Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as 'stage 0,' breast cancer, according to new research at Washington University School of Medicine in St. Louis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 18, 2016 Category: Cancer & Oncology Source Type: news

How doctors are developing new payment models for their specialties
New regulations under the Medicare Access and CHIP Reauthorization Act (MACRA) are on their way, and physicians will have a choice to participate in the new Merit-based Incentive Payment System or alternative payment models (APM). It’s important that physicians are involved and leading the way now in the design of APMs to ensure they work for both their patients and their practices. Learn how one physician got involved with his specialty society to develop new payment models. Building future payment models As a radiation oncologist in Seattle, Shilpen Patel, MD, saw opportunity in the APM option and began working...
Source: AMA Wire - April 15, 2016 Category: Journals (General) Authors: Amy Farouk Source Type: news

Radiation may help after surgery for 'soft-tissue' cancers
HealthDay News Older patients with a type of cancer called soft-tissue sarcomas may benefit more from radiation therapy after surgery than younger patients do.. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 14, 2016 Category: Consumer Health News Source Type: news

RefleXion secures more funding
Radiation therapy equipment developer RefleXion Medical has completed a $46...Read more on AuntMinnie.comRelated Reading: Mirada inks deal with RefleXion CliQr gains radiation therapy firm as client (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 14, 2016 Category: Radiology Source Type: news

Radiation May Help After Surgery for 'Soft-Tissue' Cancers
Biggest benefit was seen in people over 65, research suggests Source: HealthDay Related MedlinePlus Pages: Radiation Therapy, Soft Tissue Sarcoma, Surgery (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 14, 2016 Category: Consumer Health News Source Type: news

Radiation May Help After Surgery for 'Soft-Tissue' Cancers
THURSDAY, April 14, 2016 -- Older patients with a type of cancer called soft-tissue sarcomas may benefit more from radiation therapy after surgery than younger patients do, a new study suggests. The results might change the way older patients are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 14, 2016 Category: Journals (General) Source Type: news

IsoRay spikes GliaSite radiation therapy device
IsoRay (NYSE:ISR) said yesterday that it’s spiking its GliaSite radiation therapy system for treating brain cancers, after achieving only modest sales since the FDA cleared the device in 2011. Richland, Wash.-based IsoRay said it’s cancelling its deals with Dr. Reddy’s Laboratories (NYSE:RDY), Hologic (NSDQ:HOLX) and Karlheinz Goehl-Medizintechnik Goehl concerning GliaSite. “The GliaSite product has resulted in only marginal sales, but it was the first delivery system available to the company to deliver brachytherapy radiation in the treatment of brain cancer. Management believes...
Source: Mass Device - April 13, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Oncology Radiosurgery IsoRay Source Type: news

The holistic health approach is the best way to fight cancer fatigue
(NaturalNews) Many people are unaware that fatigue is the most common side effect of traditional cancer treatments. In fact, there is research suggesting that most people receiving traditional cancer treatment, including chemotherapy and radiation therapy, are beset with fatigue,... (Source: NaturalNews.com)
Source: NaturalNews.com - April 12, 2016 Category: Consumer Health News Source Type: news

Red Journal's May 2016 edition features special focus on particle therapy
(American Society for Radiation Oncology) The International Journal of Radiation Oncology Biology Physics' (Red Journal) May edition is a special issue focused entirely on particle therapy. It will feature papers showcasing the 'best available evidence' on the value of particle therapy, as well as editorials and commentaries about its place in the radiation therapy (RT) arsenal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 12, 2016 Category: Cancer & Oncology Source Type: news

Moffitt researchers discover liver metastases have different radiation sensitivities
(H. Lee Moffitt Cancer Center & Research Institute) Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors that predict patient outcomes are unclear. Moffitt Cancer Center researchers report that liver metastases have different sensitivities to radiation therapy based on the location of the primary tumor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 12, 2016 Category: Cancer & Oncology Source Type: news

Radiation improves survival in older patients with soft tissue sarcomas
Radiation therapy following surgery benefits older patients more than their younger counterparts, researchers report, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 11, 2016 Category: Science Source Type: news

Common prostate cancer treatments suppress immune response, may promote relapse
Prostate cancer patients and their doctors may want to think twice about the best timing for chemotherapy or radiation therapy in conjunction with a common nonsurgical treatment, based on international research findings. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 8, 2016 Category: Science Source Type: news

Radiation therapy chemotherapy combination improves survival in adults with low-grade brain cancer
Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than patients who received radiation therapy alone, according to the results of the clinical trial. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 7, 2016 Category: Science Source Type: news

Radiation therapy masks transformed into artistic masterpieces for fundraiser April 14
Radiation therapy masks used during cancer treatments that have been transformed into works of art by Central New York artists and art students will be auctioned off Thursday, April 14 to benefit the head and neck cancer fund at the Upstate Cancer Center. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - April 7, 2016 Category: Universities & Medical Training Source Type: news

Common prostate cancer treatments suppress immune response and may promote relapse
(UT Southwestern Medical Center) Prostate cancer patients and their doctors may want to think twice about the best timing for chemotherapy or radiation therapy in conjunction with a common nonsurgical treatment, based on international research findings led by UT Southwestern Medical Center investigators. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 7, 2016 Category: Global & Universal Source Type: news

Adding chemo to radiation boosts survival from low-grade gliomas
Adding a chemotherapy combination to radiation therapy for initial treatment of low-grade gliomas significantly improved overall survival and progression-free survival, regardless of the tumor type,... (Source: Clinical Neurology News)
Source: Clinical Neurology News - April 6, 2016 Category: Neurology Source Type: news

High-Dose Radiation May Be No Better for Low-Risk Prostate Cancer
Study finds no benefits in disease progression, survival Source: HealthDay Related MedlinePlus Pages: Prostate Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 6, 2016 Category: Consumer Health News Source Type: news

Combined chemotherapy and radiation therapy assists low-grade glial brain tumors
(NRG Oncology) The Radiation Therapy Oncology Group, now conducting research as NRG Oncology, initiated the trial RTOG 9802 (A Phase III Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma) in an effort to improve patient survival. NRG Oncology researchers report the long-term results of this randomized clinical trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2016 Category: Cancer & Oncology Source Type: news

Radiation therapy chemotherapy combination improves survival in adults with low-grade brain cancer
(Mayo Clinic) Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than patients who received radiation therapy alone, according to the results of the clinical trial, Radiation Therapy Oncology Group (RTOG) 9802 published in the April 7 issue of the New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2016 Category: Cancer & Oncology Source Type: news

What is the Purpose of a Radiation Therapy Port...
Learn about what a port film is, including it's purpose during breast radiation therapy, how often it's taken, and whether it affects your total radiation dose. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - April 5, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

Radiation Therapy Chemotherapy Combination Improves Survival in Adults with Low-Grade Brain Cancer
ROCHESTER, Minn. — Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than patients who received radiation therapy alone, according to the results of the clinical trial, Radiation Therapy Oncology Group (RTOG) 9802 [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - April 5, 2016 Category: Hospital Management Source Type: news

The power and promise of 3D printing: Part 1
In the first part of a two-part series, we examine the power and promise of...Read more on AuntMinnie.comRelated Reading: CT helps 3D printing get wounded warriors back in action CT, 3D printing help team separate conjoined girls 3D images aid selection of heart transplant donors Tips for implementing 3D printing at your hospital 3D printing helps shape radiation therapy to patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2016 Category: Radiology Source Type: news

Shorter, intensive radiation works for prostate cancer: Study
HealthDay News A slightly higher dose of radiation therapy for early stage prostate cancer may reduce treatment time without compromising effectiveness, researchers report. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 4, 2016 Category: Consumer Health News Source Type: news

Shorter, Intensive Radiation Works for Prostate Cancer
The trial focused on early-stage disease that hadn't spread beyond the gland Source: HealthDay Related MedlinePlus Pages: Prostate Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 4, 2016 Category: Consumer Health News Source Type: news

Shorter, Intensive Radiation Works for Prostate Cancer: Study
MONDAY, April 4, 2016 -- A slightly higher dose of radiation therapy for early stage prostate cancer may reduce treatment time without compromising effectiveness, researchers report. The study included about 1,100 men with early-stage prostate... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 4, 2016 Category: Journals (General) Source Type: news

Shorter, Intensive Radiation Can Be Recommended in Early Prostate Cancer
This study has implications for public policy,” said the study’s principal investigator, W. Robert Lee, M.D., a professor in the Department of Radiation Oncology at Duke. “Because the shorter regimen has advantages such as greater patient convenience and lower costs, it’s important to establishing whether we can cure as many patients with the shorter regimen. Our study provides that information for the first time.” Lee and colleagues, working as part of NRG Oncology, a non-profit cancer research organization, enrolled about 1,100 men whose prostate cancer was diagnosed early, before it had spr...
Source: DukeHealth.org: Duke Health Features - April 4, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Radiation Therapy Chemotherapy Combination Improves Survival in Adults with Low-Grade Brain Cancer
ROCHESTER, Minn. — Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than patients who received radiation therapy alone, according to the results of the clinical trial, Radiation Therapy Oncology Group (RTOG) 9802 [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 31, 2016 Category: Databases & Libraries Source Type: news

Study finds adaptive IGRT for bladder preservation clinically feasible
(American Society for Radiation Oncology) A prospective study examining a trimodality treatment approach in localized bladder cancer cases using adaptive image-guided, intensity-modulated radiation therapy (IG-IMRT) found that the bladder preservation rate at three years was 83 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 29, 2016 Category: Cancer & Oncology Source Type: news

Distance Matters for Quality Rectal Cancer Care
The farther a patient has to travel for radiation therapy, the less likely it will happen, study finds (Source: U.S. News - Health)
Source: U.S. News - Health - March 25, 2016 Category: Consumer Health News Source Type: news

Distance Matters for Quality Rectal Cancer Care
The farther a patient has to travel for radiation therapy, the less likely it will happen, study finds Source: HealthDay Related MedlinePlus Pages: Colorectal Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 25, 2016 Category: Consumer Health News Source Type: news

Distance Matters for Quality Rectal Cancer Care
FRIDAY, March 25, 2016 -- Patients who must travel long distances for rectal cancer radiotherapy are less likely to get the potentially lifesaving treatment, a new study shows. "Travel burden clearly creates a barrier to radiation therapy access for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 25, 2016 Category: Journals (General) Source Type: news

Varian opens office in Algeria
Radiation therapy firm Varian Medical Systems has expanded its operations in...Read more on AuntMinnie.comRelated Reading: Varian launches new Beacon transponder Varian preps new products for ECR 2016 Varian posts mixed Q1 results Varian gets Saudi OK for proton therapy system Varian sees slight revenue increase in 2015 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 25, 2016 Category: Radiology Source Type: news

Distance Matters for Quality Rectal Cancer Care
The farther a patient has to travel for radiation therapy, the less likely it will happen, study finds (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - March 25, 2016 Category: Cancer & Oncology Source Type: news

Distance Matters for Quality Rectal Cancer Care
The farther a patient has to travel for radiation therapy, the less likely it will happen, study finds (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 24, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, News, Source Type: news

PET/CT after therapy avoids surgery for head, neck cancer
Using PET/CT scans to assess response to therapy can help patients with head...Read more on AuntMinnie.comRelated Reading: 3-month PET/CT helps track oropharyngeal cancer Interrupted radiation therapy risks cancer recurrence PET/CT details hint at survival of head and neck cancer patients Oral HPV infection increasing in young men PET/CT prevents dissections for head and neck cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 24, 2016 Category: Radiology Source Type: news

New technology may cut length of prostate cancer treatment
Stephen FellerSYDNEY, Austria, March 23 (UPI) -- A new technology could improve accuracy of prostate cancer radiation therapy, potentially cutting the number of treatments a patient needs from 40 to five. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 23, 2016 Category: Consumer Health News Source Type: news

Varian launches new Beacon transponder
Radiation therapy firm Varian Medical Systems has launched a Calypso 17-gauge...Read more on AuntMinnie.comRelated Reading: Varian preps new products for ECR 2016 Varian posts mixed Q1 results Varian gets Saudi OK for proton therapy system Varian sees slight revenue increase in 2015 Varian to develop radiotherapy training program in India (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 23, 2016 Category: Radiology Source Type: news

Former Toronto Mayor Rob Ford's Rare Abdominal Cancer, Explained
Rob Ford, the controversial former Toronto mayor who was known both for smoking crack cocaine in office and his intense popularity among conservative working-class voters, died today at the age of 46. The cause of death was not announced, but Ford was being treated for rare abdominal cancer called pleomorphic liposarcoma -- a diagnosis he received in 2014.  "It's rare to have a highly successful outcome with a pleomorphic liposarcoma once it's spread," Dr. Brian Van Tine, a medical oncologist at Washington University in St. Louis, told the Canadian Press.  Liposarcomas belong to a class of tumors t...
Source: Science - The Huffington Post - March 22, 2016 Category: Science Source Type: news

Former Toronto Mayor Rob Ford's Rare Abdominal Cancer, Explained
Rob Ford, the controversial former Toronto mayor who was known both for smoking crack cocaine in office and his intense popularity among conservative working-class voters, died today at the age of 46. The cause of death was not announced, but Ford was being treated for rare abdominal cancer called pleomorphic liposarcoma -- a diagnosis he received in 2014.  "It's rare to have a highly successful outcome with a pleomorphic liposarcoma once it's spread," Dr. Brian Van Tine, a medical oncologist at Washington University in St. Louis, told the Canadian Press.  Liposarcomas belong to a class of tumors t...
Source: Healthy Living - The Huffington Post - March 22, 2016 Category: Consumer Health News Source Type: news

Varian Launches New Smaller Calypso Beacon Transponder To Guide Radiation Therapy In Soft Tissue Tumors
New transponder receives FDA 510(K) clearance and CE Mark PALO ALTO, Calif., March 22, 2016 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced a new Calypso® 17G soft tissue Beacon® transponder that is 50 ... Devices, Oncology, FDA, Regulatory, Product LaunchVarian Medical Systems, Calypso, Beacon transponder, radiotherapy, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 22, 2016 Category: Pharmaceuticals Source Type: news

Florida Cancer Affiliates First in the State Certified to Offer New Spacing Device to Benefit Prostate Cancer Patients
Trinity, Florida (March 22, 2016) - Florida Cancer Affiliates (FCA) is helping to pioneer a new tool aimed to protect prostate cancer patients from the negative effects of radiation therapy. Recently a patient, one of the first in Florida, was injected at FCA with SpaceOAR® hydrogel, the first FDA c... (Source: McKesson News)
Source: McKesson News - March 22, 2016 Category: Information Technology Source Type: news